Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-15

FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals’ supplemental ANDA for oxycodone and acetaminophen tablets, enabling the marketing of the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXYCODONE AND ACETAMINOPHEN (oxycodone and acetaminophen)

Snippet

SUPPL AP for OXYCODONE AND ACETAMINOPHEN (OXYCODONE AND ACETAMINOPHEN)